EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microglia in ALS: Insights into Mechanisms and Therapeutic Potential

Silvano Bond, Smita Saxena iD, Julieth A Sierra-Delgado iD

Cells · 12.03.2025 · 14 (6) · 421

DOI: 10.3390/cells14060421 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 12.03.2025. Verfasst von Silvano Bond und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, University of Missouri School of Medicine, Columbia, MO 65211, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Microglia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rare Village, Radala Foundation, University of Missouri- Columbia, School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the loss of motor neurons, leading to escalating muscle weakness, atrophy, and eventually paralysis. While neurons are the most visibly affected, emerging data highlight microglia—the brain’s resident immune cells—as key contributors to disease onset and progression. Rather than existing in a simple beneficial or harmful duality, microglia can adopt multiple functional states shaped by internal and external factors, including those in ALS. Collectively, these disease-specific forms are called disease-associated microglia (DAM). Research using rodent models, patient-derived cells, and human postmortem tissue shows that microglia can transition into DAM phenotypes, driving inflammation and neuronal injury. However, these cells can also fulfill protective roles under certain conditions, revealing their adaptable nature. This review explores recent discoveries regarding the multifaceted behavior of microglia in ALS, highlights important findings that link these immune cells to motor neuron deterioration, and discusses emerging therapies—some already used in clinical trials—that aim to recalibrate microglial functions and potentially slow disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMicrogliaHumansAnimalsMotor Neurons

Stichwörter der Autor:innen

ALSmicroglianeuroinflammation

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, University of Missouri School of Medicine, Columbia, MO 65211, USA.
  • NextGen Precision Health, University of Missouri, Columbia, MO 65211, USA.

ORCID-Profile: Smita Saxena, Julieth A Sierra-Delgado

Förderung

  • Rare Village
  • Radala Foundation
  • University of Missouri- Columbia, School of Medicine
  • University of Missouri School of Medicine

Zitieren

APA

Bond, S., Saxena, S., & Sierra-Delgado, J. A. (2025). Microglia in ALS: Insights into Mechanisms and Therapeutic Potential. Cells, 14(6), 421. https://doi.org/10.3390/cells14060421

Vancouver

Bond S, Saxena S, Sierra-Delgado JA. Microglia in ALS: Insights into Mechanisms and Therapeutic Potential. Cells. 2025;14(6):421. doi:10.3390/cells14060421

BibTeX
@article{Bond2025,
  author = {Bond, Silvano and Saxena, Smita and Sierra-Delgado, Julieth A},
  title = {Microglia in ALS: Insights into Mechanisms and Therapeutic Potential},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {6},
  pages = {421},
  doi = {10.3390/cells14060421}
}
Kostenlos starten →